Skip to main content
. 2023 Apr 15;7(14):3658–3665. doi: 10.1182/bloodadvances.2023009707

Table 2.

Comparison of PRO scores between adults with SCD who likely have chronic pain and those who likely do not have chronic pain

PRO domains Chronic pain (n = 14)
Median (IQR)
No chronic pain (n = 19)
Median (IQR)
P value
Pain-related
 PROMIS pain interference 64.2 (60.5-68.7) 54.3 (45.7-59) .001
 PROMIS pain behavior 63.2 (61.9-65) 50 (35.3-60.1) .004
 ASCQ-Me pain impact 42.9 (37.3-48.4) 53.2 (42.5-65.8) .013
Pain quality
 PROMIS nociceptive 47.5 (44.4-50.5) 37 (30-64.9) .305
 PROMIS neuropathic 51.8 (50.4-54.4) 37 (37-50.4) .006
 painDETECT 15 (11.8-22.8) 9 (6-12) .011
Nonpain-related
 PROMIS fatigue 60.7 (56.5-69.7) 52.8 (45.2-60.4) .032
 PROMIS sleep disturbance 63 (57-65.8) 56.5 (44.2-60.2) .014
 PROMIS depression 54.9 (51.2-62.2) 48.2 (34.2-57.5) .026
 PROMIS anxiety 59.7 (52.4-70.8) 53.1 (38.4-65.6) .078
 ASCQ-Me emotional impact 45.3 (39.2-51.7) 60.3 (44.5-67.4) .019

Significant P values are shown in bold.

FDR, false discovery rate.

FDR adjusted P values based on Mann-Whitney U test.